| Term 
 | Definition 
 
        | β agonist, bronchodilator, |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | lipophilic (CNS) alter, release of fatigue, enhanced performance, euphoria |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | β 1 selective, partial agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | (like cocaine) inhibit NET , CNS effects (ADHD) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | mixed α / β antagonists, higher β : α ratio than labetolol , anti-oxidant activity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | produce convulsions, cerebral hemorrhage, arrhythmias or MI, (inhibits NET) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | α2 agonist, hypertension, CNS acting (↓ sympathetic tone via NTS receptors) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | lipophilic (CNS) alter, release of fatigue, enhanced performance, euphoria, less peripheral side effects & tolerance (tachyphylaxis) develops quickly |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | β 1 , (lesser extent α 1), inactive on dopamine receptors |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | natural, congener (same family) of amphetmaine, releases NE, long duration (not metabolized by MAO), non- α β selective, bronchodilation, vasodilation, ↑ heart rate, modest CNS stimulation (not very lipophilic) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | same affinity for all receptors, α & β agonist , little CNS, ↑ blood glucose, ↑ glycogenolysis, ↑ gluconeogenesis, ↑ free fatty acids, stimulation of triglyceride lipase, ↓ insulin secretion |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | α 2 agonist, anti-hypertensive b/c of ↓ sympathetic tone via receptors in the NTS brainstem (reflex) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | supress α & β effects (↓ sympathetic tone):  hypotenison, bradycardia, ↓ cardiac output, treats hypertension |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | α 2 agonist, anti-hypertensive b/c of ↓ sympathetic tone via receptors in the NTS brainstem (reflex) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | β selective (not subtype selective), ↑ bp , dilate skeletal muscle , ↓ TPR & diastolic BP, bronchodilator |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | mixed α / β antagonists, lower β: α ratio than carvedilol |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | lipophilic (CNS) alter, release of fatigue, enhanced performance, euphoria, less peripheral side effects & tolerance (tachyphylaxis) develops quickly |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | α 2 agonist, anti-hypertensive b/c of ↓ sympathetic tone via receptors in the NTS brainstem (reflex) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | amphetamine variant, ADHD, habit forming:  psychosis, aggression, cardiac events |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | β 1 Blocker:  cardiac arrhythmia , angina pectoris, hypertension, post MI (partial agonist) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | lower β 2 affinity than anyother receptor, α & β agonist , little CNS, ↑ blood glucose, ↑ glycogenolysis, ↑ gluconeogenesis, ↑ free fatty acids, stimulation of triglyceride lipase, ↓ insulin secretion |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | α agonist, nasal decongestant, local vasoconstrictor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | α blocker, severe hypotension, little effect on resting blood pressure |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | potent α1 α2 blocker, reduces TPR by vasodilation, cardiac stimulation by blocking epinephrine (reflex) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | α agonist, nasal decongestant, local vasoconstrictor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | α1 blocker, dilates arterioles & veins, hypotension by reducing peripheral resistance, ↓ cardiac pre-load & afterload, not much tachycardia (doesn't bind α 2) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | non-selective β blocker, ↓ HR & output, reflex ↑ peripheral resistance, chronic use ↓ blood pressure, effects very prominent during exercise & stress, ↓ anxiety, ↓ renin, ↑ bronchoconstriciton |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | α agonist, nasal decongestant, local vasoconstrictor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | natural, prevents vesicle storage, depelets dopamine, epinephrine, norepinephrine, and serotonin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | α 1 blocker, BPH, less effective in ↓ TPR than other α antagonists |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1QD = α1 blocker, dilates arterioles & veins, hypotension by reducing peripheral resistance, ↓ cardiac pre-load & afterload, not much tachycardia (doesn't bind α 2) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | beta 2 agonist, bronchodilator, uterine relaxant |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | α agonist, (visine ®) constrict conjunctiva vessels, local vasoconstrictor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | non-selective β blocker, opthalmic:  glaucoma, no local anestetic effect, |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MAO inhibitor, treat depression |  | 
        |  |